AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2020
Dec 17, 2020
35334_dirs_2020-12-17_5514fe35-09bc-4b5f-aa47-888822dd689a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2020-12-17
Reporting Person: EQUELS THOMAS K. (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-17 | Common Stock | P | 14535 | $1.72 | Acquired | 198568 | Direct |
More from AIM ImmunoTech Inc.
Share Issue/Capital Change
2026
Jun 11
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15